Can iron serve as oocyte quality indicator in endometriosis?

In: The Innovation Medicine · 2025 · vol. 3(2) , pp. 100130 · doi:10.59717/j.xinn-med.2025.100130 · W4409958191
article OA: diamond CC0 ⤵ 1 in-corpus citation
AI-generated summary by claude@2026-06, 2026-06-08

This review examines how altered iron levels in follicular fluid may relate to diminished oocyte quality in endometriosis-associated infertility and discusses challenges for its clinical use.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-06, 2026-06-08 · read from full text

This paper is a perspective that synthesizes evidence on altered iron content in follicular fluid (FF) and corresponding oocyte quality outcomes in endometriosis-associated infertility, including proposed detection approaches and correlational findings. The authors report that dysregulated FF iron levels in endometriosis patients may be associated with diminished oocyte quality, drawing on prior mechanistic and observational studies. A key caveat emphasized is that translating FF iron content into a clinical evaluation indicator is hindered by multiple challenges, with calls for standardized detection and assessment protocols. This paper is centrally about endometriosis — it focuses on whether FF iron can function as an oocyte quality indicator in endometriosis-related infertility.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Endometriosis (EMs) is a significant cause of female infertility, and recent attention has focused on the relationship between iron levels in follicular fluid (FF) and oocyte quality. This perspective summarizes the characteristics of altered FF iron content and oocyte quality in EMs-associated infertility patients, along with detection methods and correlative studies. Current research indicates that dysregulated iron levels in the FF of EMs patients may be associated with diminished oocyte quality. However, the clinical utilization of FF iron content as an evaluation indicator faces multiple challenges. Future investigations should prioritize elucidating the regulatory mechanisms of iron homeostasis in the FF of EMs patients, establishing standardized detection and evaluation protocols, and providing novel insights for assisted reproductive therapies in EMs-related infertility cases.
Full text 3,596 characters · extracted from oa-doi-fallback · 2 sections · click to expand

Abstract

Endometriosis (EMs) is a significant cause of female infertility, and recent attention has focused on the relationship between iron levels in follicular fluid (FF) and oocyte quality. This perspective summarizes the characteristics of altered FF iron content and oocyte quality in EMs-associated infertility patients, along with detection methods and correlative studies. Current research indicates that dysregulated iron levels in the FF of EMs patients may be associated with diminished oocyte quality. However, the clinical utilization of FF iron content as an evaluation indicator faces multiple challenges. Future investigations should prioritize elucidating the regulatory mechanisms of iron homeostasis in the FF of EMs patients, establishing standardized detection and evaluation protocols, and providing novel insights for assisted reproductive therapies in EMs-related infertility cases. -

References

[1] Li Y., He Y., Cheng W., et al. (2023). Double-edged roles of ferroptosis in endometriosis and endometriosis-related infertility. Cell Death Discov. 9:306. DOI:10.1038/s41420-023-01606-8 [2] Li A., Ni Z., Zhang J., et al. (2020). Transferrin insufficiency and iron overload in follicular fluid contribute to oocyte dysmaturity in infertile women with advanced endometriosis. Front Endocrinol. 11:391. DOI:10.3389/fendo.2020.00391 [3] Sanchez A. M., Papaleo E., Corti L., et al. (2014). Iron availability is increased in individual human ovarian follicles in close proximity to an endometrioma compared with distal ones. Hum. Reprod. 29:577−583. DOI:10.1093/humrep/det466 [4] Wu Y., Yang R., Lan J., et al. (2023). Iron overload modulates follicular microenvironment via ROS/HIF-1α/FSHR signaling. Free Radic. Biol. Med. 196:37−52. DOI:10.1016/j.freeradbiomed.2022.12.105 [5] Collodel G., Gambera L., Stendardi A., et al. (2023). Follicular fluid components in reduced ovarian reserve, endometriosis, and idiopathic infertility. Int. J. Mol. Sci. 24:2589. DOI:10.3390/ijms24032589 [6] Holmes-Hampton G. P., Tong W. H. and Rouault T. A. (2014). Biochemical and biophysical methods for studying mitochondrial iron metabolism. Methods Enzymol. 547:275−307. DOI:10.1016/b978-0-12-801415-8.00015-1 [7] Li H., Yue H., Li H., et al. (2025). High-throughput point-of-care serum iron testing utilizing machine learning-assisted deep eutectic solvent fluorescence detection platform. J. Colloid. Interface Sci. 680:389−404. DOI:10.1016/j.jcis.2024.11.110 [8] Wang F., Glenn A. J., Tessier A. J., et al. (2024). Integration of epidemiological and blood biomarker analysis links haem iron intake to increased type 2 diabetes risk. Nat. Metab. 6:1807−1818. DOI:10.1038/s42255-024-01109-5 [9] Ni Z., Li Y., Song D., et al. (2022). Iron-overloaded follicular fluid increases the risk of endometriosis-related infertility by triggering granulosa cell ferroptosis and oocyte dysmaturity. Cell Death Dis. 13:579. DOI:10.1038/s41419-022-05037-8 [10] Rodríguez-Varela C. and Labarta E. (2020). Clinical application of antioxidants to improve human oocyte mitochondrial function: A review. Antioxidants 9:1197. DOI:10.3390/antiox9121197 - ABOUT THIS ARTICLE Cite this article: Ni Z., Li Y. and Yu C. (2025). Can iron serve as oocyte quality indicator in endometriosis? The Innovation Medicine 3:100130. https://doi.org/10.59717/j.xinn-med.2025.100130 To request copyright permission to republish or share portions of our works, please visit Copyright Clearance Center's (CCC) Marketplace website at marketplace.copyright.com. - Figure 1. Challenges in assessing iron levels in follicular fluid

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosisinfertility

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (10)

Cited by (1)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK